Cargando…

Analysis of serum metabolomics among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls

Type 2 diabetes mellitus (T(2)DM) has a rising prevalence and diabetic nephropathy (DN) is a major complication of T(2)DM. Metabolomics could provide novel insights into the pathogenesis, so we aimed to explore serum metabolomic profiles from DN to T(2)DM. Serum samples were collected from 14 biopsy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Sibei, Zheng, Wen, Liu, Yuan, Li, Ling, Li, Lingzhi, Ren, Qian, Shi, Min, Liu, Jing, Jiang, Jing, Ma, Huichao, Huang, Zhuo, Xia, Zijing, Pan, Jing, Wei, Tiantian, Wang, Yan, Li, Peiyun, Lan, Tian, Ma, Liang, Fu, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2019
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064812/ https://www.ncbi.nlm.nih.gov/pubmed/35516902 http://dx.doi.org/10.1039/c9ra01561b

Ejemplares similares

Alterations of gut microbiota in biopsy-proven diabetic nephropathy and a long history of diabetes without kidney damage
por: Lu, Xiao, et al.
Publicado: (2023)

Urinary Exosomal MicroRNA Signatures in Nephrotic, Biopsy-Proven Diabetic Nephropathy
por: Lee, Wen-Chin, et al.
Publicado: (2020)

Long-Term Outcomes of Japanese Type 2 Diabetic Patients With Biopsy-Proven Diabetic Nephropathy
por: Shimizu, Miho, et al.
Publicado: (2013)

Comparison of Performance of Equations for Estimated Glomerular Filtration Rate in Chinese Patients with Biopsy-Proven Diabetic Nephropathy
por: Wang, Yiting, et al.
Publicado: (2019)

The CNDP1 (CTG)(5) Polymorphism Is Associated with Biopsy-Proven Diabetic Nephropathy, Time on Hemodialysis, and Diabetes Duration
por: Albrecht, Thomas, et al.
Publicado: (2017)

Research: Complications Impact of tubulointerstitial lesions on anaemia in patients with biopsy-proven diabetic nephropathy
por: Mise, K, et al.
Publicado: (2015)

Analysis of biopsy-proven nephrotic syndrome in Tibetan patients
por: Huang, Rongshuang, et al.
Publicado: (2022)

Severe 25-Hydroxyvitamin D Deficiency May Predict Poor Renal Outcomes in Patients With Biopsy-Proven Diabetic Nephropathy
por: Zhou, Ting, et al.
Publicado: (2022)

Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
por: Zhao, L., et al.
Publicado: (2021)

Paratubular basement membrane insudative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
por: Mise, Koki, et al.
Publicado: (2017)

Biopsy-proven acute phosphate nephropathy: A case report
por: Medina-Liabres, Kristianne Rachel Palanca, et al.
Publicado: (2020)

Clinical Outcomes in Patients With Biopsy Proven Anticoagulant-Related Nephropathy
por: Dasgupta, Alana, et al.
Publicado: (2023)

Pharmacological and genetic inhibition of fatty acid‐binding protein 4 alleviated cisplatin‐induced acute kidney injury
por: Tan, Zhouke, et al.
Publicado: (2019)

Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathy
por: Okada, Sadanori, et al.
Publicado: (2020)

Activation of aryl hydrocarbon receptor by 6‐formylindolo[3,2‐b]carbazole alleviated acute kidney injury by repressing inflammation and apoptosis
por: Tao, Sibei, et al.
Publicado: (2020)

Is preclinical diabetic retinopathy in diabetic nephropathy individuals more severe?
por: Yao, Hongyan, et al.
Publicado: (2023)

Impact of the relationship between hemoglobin levels and renal interstitial fibrosis on long-term outcomes in type 2 diabetes with biopsy-proven diabetic nephropathy
por: Shimizu, Miho, et al.
Publicado: (2021)

C3c deposition predicts worse renal outcomes in patients with biopsy‐proven diabetic kidney disease in type 2 diabetes mellitus
por: Li, Meng‐Rui, et al.
Publicado: (2022)

Clinicopathological characteristics and risk factors in elderly patients with biopsy-proven IgA nephropathy
por: Tan, Jiaxing, et al.
Publicado: (2022)

Lower bile acids as an independent risk factor for renal outcomes in patients with type 2 diabetes mellitus and biopsy-proven diabetic kidney disease
por: Xiao, Xiang, et al.
Publicado: (2022)

Integration of Metabolomics and Proteomics in Exploring the Endothelial Dysfunction Mechanism Induced by Serum Exosomes From Diabetic Retinopathy and Diabetic Nephropathy Patients
por: Yang, Jing, et al.
Publicado: (2022)

The triglyceride glucose index can predict newly diagnosed biopsy-proven diabetic nephropathy in type 2 diabetes: A nested case control study
por: Shang, Jin, et al.
Publicado: (2019)

Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus
por: Zhuo, Li, et al.
Publicado: (2013)

Epidemiology of biopsy‐proven glomerular diseases in Chinese children: A scoping review
por: Li, Yetong, et al.
Publicado: (2022)

A nationwide cross-sectional analysis of biopsy-proven Fabry nephropathy: the Japan Renal Biopsy Registry
por: Nasu, Makoto, et al.
Publicado: (2022)

Early-onset of type 2 diabetes mellitus is a risk factor for diabetic nephropathy progression: a biopsy-based study
por: Wu, Yucheng, et al.
Publicado: (2021)

Association of ANGPTL8 and Resistin With Diabetic Nephropathy in Type 2 Diabetes Mellitus
por: Li, Mengni, et al.
Publicado: (2021)

Letter Regarding Normal Albuminuria in Patients With Autopsy-Proven Advanced Diabetic Nephropathy
por: Heyman, Samuel N., et al.
Publicado: (2022)

Implications of a Family History of Diabetes and Rapid eGFR Decline in Patients With Type 2 Diabetes and Biopsy-Proven Diabetic Kidney Disease
por: Wang, Yiting, et al.
Publicado: (2019)

Current findings of kidney biopsy including nephropathy associated with hypertension and diabetes mellitus in Korea
por: Kim, Kipyo, et al.
Publicado: (2020)

The Spectrum of Biopsy-Proven Glomerular Disease in China: A Systematic Review
por: Yang, Yue, et al.
Publicado: (2018)

Association Between Serum Asprosin and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus in the Community: A Cross-Sectional Study
por: Xu, Linxin, et al.
Publicado: (2022)

Response to “Letter Regarding Normal Albuminuria in Patients With Autopsy-Proven Advanced Diabetic Nephropathy”
por: Sasaki, Takaya, et al.
Publicado: (2022)

Establishment of an Inflamed Animal Model of Diabetic Nephropathy
por: Ma, Kun Ling, et al.
Publicado: (2014)

Current progress in metabolomics of gestational diabetes mellitus
por: Wang, Qian-Yi, et al.
Publicado: (2021)

Identifying Potential Diagnostic Genes for Diabetic Nephropathy Based on Hypoxia and Immune Status
por: Li, Changyan, et al.
Publicado: (2021)

A case of biopsy-proven chronic kidney disease on progression from acute phosphate nephropathy
por: Joo, Woo Chul, et al.
Publicado: (2012)

Effect of resveratrol in gestational diabetes mellitus and its complications
por: Ma, Hui-Zhong, et al.
Publicado: (2023)

Prevalence of diabetic nephropathy in the diabetes mellitus population: A protocol for systematic review and meta-analysis
por: Li, Sicheng, et al.
Publicado: (2022)

VEGF Genetic Polymorphisms May Contribute to the Risk of Diabetic Nephropathy in Patients with Diabetes Mellitus: A Meta-Analysis
por: Sun, Li, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2ak5f198e5eto49jhgh35u983d